Expression of IL-26 predicts prognosis of patients with hepatocellular carcinoma after surgical resection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Expression of IL-26 predicts prognosis of patients with hepatocellular carcinoma after surgical resection

Published:2019-06 Issue:3 Volume:18 Page:242-248
ISSN:1499-3872
Container-title:Hepatobiliary & Pancreatic Diseases International
language:en
Short-container-title:Hepatobiliary & Pancreatic Diseases International

Author:

Xi Zhi-Feng,Jeong Seogsong,Wang Chen-Chen,Li Hong-Jie,Guo Han,Cai Jie,Li Jia-Xin,Kong Xiao-Ni,Tong Ying,Xia Qiang

Funder

National Natural Science Foundation of China

Shanghai Municipal Education Commission

National Key R&D Program for Precision Medicine

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference25 articles.

1. Hepatocellular carcinoma;Forner;Lancet,2018

2. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine;Fujiwara;J Hepatol,2018

3. Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines;Ayuso;Eur J Radiol,2018

4. Molecular therapies and precision medicine for hepatocellular carcinoma;Llovet;Nat Rev Clin Oncol,2018

5. Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: an attempt to perform an ideal meta-analysis;Menahem;Liver Transpl,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunobiology of IL-26;Journal of Investigative Dermatology;2024-06

2. Identification of Biomarkers Related to the Efficacy of Radiotherapy in Pancreatic Cancer;Cancer Genomics - Proteomics;2023

3. Progress on Factors Affecting the Recurrence and Prognosis of Hepatocellular Carcinoma after Resection;Advances in Clinical Medicine;2022

4. A comprehensive review of IL‐26 to pave a new way for a profound understanding of the pathobiology of cancer, inflammatory diseases and infections;Immunology;2021-11-08

5. IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor resistance through endoplasmic reticulum stress signaling pathway in triple-negative breast cancer cells;Cell Death & Disease;2021-05-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3